Healthy volunteers needed to test safety of experimental drug M5542
NCT ID NCT06577337
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 20 times
Summary
This early-stage study is testing a new drug, M5542, in healthy adults to see if it is safe and how the body processes it. About 49 participants will receive either a single dose of M5542 or a placebo by injection. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology Unit of Nuvisan GmbH
RECRUITINGNeu-Ulm, Germany
Conditions
Explore the condition pages connected to this study.